News > September > 2013

16th September 2013

Diurnal announces positive progress in Chronocort Phase 2 trial

Fusion IP plc (AIM: FIP), the university commercialisation company that turns world-class research into business, is pleased to announce that its portfolio company, Diurnal, a spin-out from the University of Sheffield, has successfully completed the pharmacokinetic part of its Phase 2 CATCH (Chronocort® As Treatment for Congenital Adrenal Hyperplasia) clinical study. Based in Cardiff, Diurnal…

10th September 2013

MediWales’ Member EKF Diagnostics Leads Global Master Class Series in Diabetes and Anemia Testing and Monitoring

Cardiff, UK – 10th September 2013 – EKF Diagnostics, the global point-of-care diagnostics business, announces today that it is going the extra mile to fully support and train its customers. Already this year, EKF experts have travelled in excess of 80,000 miles to deliver the company’s 2013 Master Class Series. This series is designed to…